The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Co-occurring genomic alterations and association with progression free survival in BRAFV600 mutated non-melanoma tumors treated with BRAF inhibitor.
 
Shiraj Sen
No Relationships to Disclose
 
Arvind Rao
No Relationships to Disclose
 
Filip Janku
Consulting or Advisory Role - Deciphera; Trovagene
Research Funding - Biocartis; BioMed Valley Discoveries; Foundation Medicine; Novartis; Roche; Trovagene
Other Relationship - Bio-Rad
 
David S. Hong
Research Funding - AstraZeneca (Inst); Eisai (Inst); Genentech (Inst); miRNA Therapeutics (Inst); Novartis (Inst); Pfizer (Inst)
 
Apostolia Maria Tsimberidou
Research Funding - Baxter (Inst); EMD Serono (Inst); Foundation Medicine (Inst); ONYX (Inst)
 
Sarina Anne Piha-Paul
No Relationships to Disclose
 
John Heymach
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Exelixis; Genentech; GlaxoSmithKline; Lilly; Novartis; Synta
Research Funding - AstraZeneca; Bayer; GlaxoSmithKline
 
Lauren Averett Byers
Consulting or Advisory Role - Abbvie; AstraZeneca; Biomarin; Medivation
Research Funding - Takeda
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche
Consulting or Advisory Role - Celgene; Genentech; Inflection Biosciences; Novartis; Roche
Research Funding - Aileron Therapeutics; AstraZeneca; Bayer; Calithera Biosciences; CytomX Therapeutics; Debiopharm Group; Genentech; Novartis; PUMA Biotechnology; Taiho Pharmaceutical; Verastem
 
Vivek Subbiah
Research Funding - Abbvie (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Bioxell Pharma (Inst); D3 Oncology Solutions (Inst); Fujifilm (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche/Genentech (Inst)